Is Blue Lotus (Nymphaea caerulea) Legal in Ohio? (2026)

Instrument

statute

Source

https://codes.ohio.gov/ohio-administrative-code/rule-4729:9-1-01

Retrieved

2026-06-19

Fingerprint

a51c2f62c2f7c543

**OAC 4729:9-1-01(D) (hallucinogen scope)** — "Any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances, including their salts, isomers, and salts of isomers, unless specifically excepted under federal drug abuse control laws … (29) Psilocybin; (30) Psilocyn;"
— OAC 4729:9-1-01(D), https://codes.ohio.gov/ohio-administrative-code/rule-4729:9-1-01 (OFFICIAL, eff. Nov. 8, 2025). 4-HO-MET does not appear; the only structural catch-alls in the rule are non-tryptamine.
**R.C. 3719.013 (analog treatment)** — "a controlled substance analog, to the extent intended for human consumption, shall be treated for purposes of any provision of the Revised Code as a controlled substance in schedule I."
— R.C. 3719.013, https://codes.ohio.gov/ohio-revised-code/section-3719.013 (OFFICIAL, eff. Dec. 20, 2012). The "controlled substance analog" definition (R.C. 3719.01) uses the federal-style "substantially similar chemical structure" + "substantially similar … hallucinogenic effect" to a Schedule I/II substance.

Instrument

Controlled substance analog treated as Schedule I; controlled substance analog definition

Source

https://codes.ohio.gov/ohio-revised-code/section-3719.013

Retrieved

2026-07-20

Fingerprint

373ca483b7ef4bbe

Sec. 3719.013. Except as otherwise provided in section 2925.03 or 2925.11 of the Revised Code, a controlled substance analog, to the extent intended for human consumption, shall be treated for purposes of any provision of the Revised Code as a controlled substance in schedule I.

Sec. 3719.01(Z)(1) "Controlled substance analog" means, except as provided in division (Z)(2) of this section, a substance to which both of the following apply:
(a) The chemical structure of the substance is substantially similar to the structure of a controlled substance in schedule I or II.
(b) One of the following applies regarding the substance:
(i) The substance has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I or II.
(ii) With respect to a particular person, that person represents or intends the substance to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I or II.
(2) "Controlled substance analog" does not include any of the following:
(a) A controlled substance;
(b) Any substance for which there is an approved new drug application;
(c) With respect to a particular person, any substance if an exemption is in effect for investigational use for that person pursuant to federal law to the extent that conduct with respect to that substance is pursuant to that exemption;
(d) Any substance to the extent it is not intended for human consumption before the exemption described in division (Z)(2)(b) of this section takes effect with respect to that substance.